Pharmacotherapy

Papers
(The TQCC of Pharmacotherapy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors119
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy108
82
Warfarin dosage in a postpartum woman while breastfeeding: A case report67
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey59
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps55
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review47
Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or R42
Update and narrative review of avian influenza (H5N1) infection in adult patients41
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect38
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy38
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care35
33
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy32
Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation32
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”31
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy30
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant28
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)28
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency28
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”24
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution24
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy23
A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial22
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study22
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse22
Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐ and Full‐Thickness Skin Burns21
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures20
Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study20
Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam20
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations19
Issue Information18
Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double‐blind placebo‐controlled crossover trial18
18
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents17
Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study17
Approaches to Precision‐based Anticoagulation management in the critically Ill17
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with 17
Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Ac16
Oritavancin for Treatment of Osteomyelitis: A Systematic Review and Meta‐Analysis of Observational Studies16
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation16
Issue Information16
16
Issue Information16
Impact of dexmedetomidine in conjunction with a weaning protocol on post‐surgical opioid use in a neonatal intensive care unit16
Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”15
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections15
Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries15
15
Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study15
Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders14
Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk14
Efficacy and safety of factor Xa inhibitors in low body weight patients14
Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study14
14
Issue Information14
Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases13
Correction to “Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐and Full‐Thickness Skin Burns”13
Issue Information13
Scoping review of rational polytherapy in patients with drug‐resistant epilepsy13
Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy13
Issue Information13
A dose‐escalation clinical trial of intranasal ketamine for uncontrolled cancer‐related pain13
Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature12
Effects of statin therapy and treatment duration on cardiovascular disease risk in patients with nephrotic syndrome: A nested case–control study12
12
Risks of serious adverse events and kidney injury in patients treated with ibandronate: A systematic review and meta‐analysis12
Fluoroquinolones and the risk of aortic aneurysm or dissection: A population‐based propensity score‐matched German cohort study12
Critique of “Angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality”11
The role of inflammation in the pathogenesis and treatment of arrhythmias11
Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease11
A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults11
11
Caring for two in the ICU: Pharmacologic management of pregnancy‐related complications11
Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection10
Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids10
External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring10
Standards of practice to advance the quality of health care10
Issue Information10
Performance of different body weights in the Cockcroft‐Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort10
Myocardial infarction associated with erenumab: A case report10
Impact of medication intensification on 30‐day hospital readmissions in a geriatric trauma population: A multicenter cohort study10
Issue Information10
Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”9
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients9
Current clinical pharmacology issues in pregnancy and pediatrics9
Correction to “Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis”9
Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report9
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review9
Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers9
Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report9
Comment on “The power and pitfalls of underpowered studies”9
Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction8
Serum potassium response to single‐dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients8
Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone8
Population pharmacokinetics of linezolid and its major metabolites PNU‐142300 and PNU‐142586 in adult patients8
Impact of pre‐lung transplant statin use on the development of primary graft dysfunction8
The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review8
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation8
Emerging therapies for eosinophilic esophagitis8
Metformin use is associated with reduced acute kidney injury following coronary artery bypass grafting in patients with type 2 diabetes: An inverse probability of treatment weighting analysis8
Precision‐based approaches to delirium in critical illness: A narrative review8
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens8
The MPRINT Hub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics7
“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimi7
Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics7
Comment on “Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy”7
Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society7
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population7
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan7
Issue Information7
Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended‐Spectrum β‐lactamase prod6
6
Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service6
Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease6
In Search of Big Beautiful Biomarkers6
Cardiovascular adverse events in patients with hepatocellular carcinoma receiving vascular endothelial growth factor inhibitors6
6
Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections 6
Transfer of antibiotics and their metabolites in human milk: Implications for infant health and microbiota6
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis6
Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics6
Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy6
Prevalence of prescription medication use that can exacerbate heart failure among US adults with heart failure6
Comparison of catheter‐related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil‐based intravenous fat emulsion versus a mixed oil fat emulsion6
Effect of cilostazol on preventing paclitaxel‐induced neuropathy in patients with breast cancer: A randomized controlled trial6
Correction of posaconazole concentrations for hypoalbuminemia6
Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistantStenotrophomonas maltophilia6
Clinical outcomes associated with anti‐Xa‐monitored enoxaparin for venous thromboembolism prophylaxis6
Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case6
Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi‐site retrospective study6
Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis6
0.063807964324951